The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Disease Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Asthma
1.2.3 Chronic Obstructive Pulmonary Disease (COPD)
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market by Application
1.3.1 Global Lung Disease Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Disease Therapeutic Market Perspective (2018-2029)
2.2 Lung Disease Therapeutic Growth Trends by Region
2.2.1 Global Lung Disease Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Lung Disease Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Lung Disease Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Lung Disease Therapeutic Market Dynamics
2.3.1 Lung Disease Therapeutic Industry Trends
2.3.2 Lung Disease Therapeutic Market Drivers
2.3.3 Lung Disease Therapeutic Market Challenges
2.3.4 Lung Disease Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Disease Therapeutic Players by Revenue
3.1.1 Global Top Lung Disease Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Lung Disease Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Lung Disease Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung Disease Therapeutic Revenue
3.4 Global Lung Disease Therapeutic Market Concentration Ratio
3.4.1 Global Lung Disease Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Disease Therapeutic Revenue in 2022
3.5 Lung Disease Therapeutic Key Players Head office and Area Served
3.6 Key Players Lung Disease Therapeutic Product Solution and Service
3.7 Date of Enter into Lung Disease Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Disease Therapeutic Breakdown Data by Type
4.1 Global Lung Disease Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Lung Disease Therapeutic Forecasted Market Size by Type (2024-2029)
5 Lung Disease Therapeutic Breakdown Data by Application
5.1 Global Lung Disease Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Lung Disease Therapeutic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Lung Disease Therapeutic Market Size (2018-2029)
6.2 North America Lung Disease Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Lung Disease Therapeutic Market Size by Country (2018-2023)
6.4 North America Lung Disease Therapeutic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Disease Therapeutic Market Size (2018-2029)
7.2 Europe Lung Disease Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Lung Disease Therapeutic Market Size by Country (2018-2023)
7.4 Europe Lung Disease Therapeutic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Disease Therapeutic Market Size (2018-2029)
8.2 Asia-Pacific Lung Disease Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Lung Disease Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Lung Disease Therapeutic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung Disease Therapeutic Market Size (2018-2029)
9.2 Latin America Lung Disease Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Lung Disease Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Lung Disease Therapeutic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Disease Therapeutic Market Size (2018-2029)
10.2 Middle East & Africa Lung Disease Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Lung Disease Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Lung Disease Therapeutic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Lung Disease Therapeutic Introduction
11.1.4 GSK Revenue in Lung Disease Therapeutic Business (2018-2023)
11.1.5 GSK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Lung Disease Therapeutic Introduction
11.2.4 AstraZeneca Revenue in Lung Disease Therapeutic Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Lung Disease Therapeutic Introduction
11.3.4 Boehringer Ingelheim Revenue in Lung Disease Therapeutic Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Lung Disease Therapeutic Introduction
11.4.4 Novartis Revenue in Lung Disease Therapeutic Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Company Detail
11.5.2 Mylan Business Overview
11.5.3 Mylan Lung Disease Therapeutic Introduction
11.5.4 Mylan Revenue in Lung Disease Therapeutic Business (2018-2023)
11.5.5 Mylan Recent Development
11.6 Vertex Pharmaceuticals
11.6.1 Vertex Pharmaceuticals Company Detail
11.6.2 Vertex Pharmaceuticals Business Overview
11.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Introduction
11.6.4 Vertex Pharmaceuticals Revenue in Lung Disease Therapeutic Business (2018-2023)
11.6.5 Vertex Pharmaceuticals Recent Development
11.7 F. Hoffman La Roche
11.7.1 F. Hoffman La Roche Company Detail
11.7.2 F. Hoffman La Roche Business Overview
11.7.3 F. Hoffman La Roche Lung Disease Therapeutic Introduction
11.7.4 F. Hoffman La Roche Revenue in Lung Disease Therapeutic Business (2018-2023)
11.7.5 F. Hoffman La Roche Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Detail
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Introduction
11.8.4 Teva Pharmaceuticals Revenue in Lung Disease Therapeutic Business (2018-2023)
11.8.5 Teva Pharmaceuticals Recent Development
11.9 Cipla
11.9.1 Cipla Company Detail
11.9.2 Cipla Business Overview
11.9.3 Cipla Lung Disease Therapeutic Introduction
11.9.4 Cipla Revenue in Lung Disease Therapeutic Business (2018-2023)
11.9.5 Cipla Recent Development
11.10 Fibrogen
11.10.1 Fibrogen Company Detail
11.10.2 Fibrogen Business Overview
11.10.3 Fibrogen Lung Disease Therapeutic Introduction
11.10.4 Fibrogen Revenue in Lung Disease Therapeutic Business (2018-2023)
11.10.5 Fibrogen Recent Development
11.11 Liminal Biosciences
11.11.1 Liminal Biosciences Company Detail
11.11.2 Liminal Biosciences Business Overview
11.11.3 Liminal Biosciences Lung Disease Therapeutic Introduction
11.11.4 Liminal Biosciences Revenue in Lung Disease Therapeutic Business (2018-2023)
11.11.5 Liminal Biosciences Recent Development
11.12 PharmAkea Therapeutics
11.12.1 PharmAkea Therapeutics Company Detail
11.12.2 PharmAkea Therapeutics Business Overview
11.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Introduction
11.12.4 PharmAkea Therapeutics Revenue in Lung Disease Therapeutic Business (2018-2023)
11.12.5 PharmAkea Therapeutics Recent Development
11.13 IQVIA
11.13.1 IQVIA Company Detail
11.13.2 IQVIA Business Overview
11.13.3 IQVIA Lung Disease Therapeutic Introduction
11.13.4 IQVIA Revenue in Lung Disease Therapeutic Business (2018-2023)
11.13.5 IQVIA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details